Transcription of Idorsia Company Profile
{{id}} {{{paragraph}}}
Example: bankruptcy
Idorsia Company Profile
Idorsia Company ProfileHeadquartered in Switzerland - a biotech-hub of Europe - Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, an experienced team of over 700 highly qualified specialists dedicated to realizing our ambitious targets, a fully functional research center, and a strong balance sheet the ideal constellation to bringing R&D efforts to business overview Nine months 2018 (in CHF millions, except EPS)US GAAPNon-GAAP*Revenues2020 Operating expenses(290)(266)Operating income (loss)(271)(247)Net income (loss)(278)(249)Basic EPS( )( )Basic number of shares (weighted average)
Idorsia Company Profile Headquartered in Switzerland - a biotech-hub of Europe - Idorsia is specialized in the discovery and development of small molecules,
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: